Autologous iPSC-Derived Dopamine Neuron Transplantation(NINDS)

N/A

Report date: 2024/05/21 20:00:08

Base Information

Drug NameAutologous iPSC-Derived Dopamine Neuron Transplantation(NINDS)
Drug Alias NameAutologous midbrain dopamine neurons cell therapy(NINDS)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Neurological Disorders And Stroke
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Neurological Disorders And Stroke
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A